TITLE

Nail Penetration of Sertaconazole with a Sertaconazole-Containing Nail Patch Formulation

AUTHOR(S)
Susilo, Rudy; Korting, Hans C.; Greb, Wolfgang; Strauss, Uwe Phillip
PUB. DATE
July 2006
SOURCE
American Journal of Clinical Dermatology;2006, Vol. 7 Issue 4, p259
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND AND OBJECTIVE: Sertaconazole, an imidazole antifungal drug, has been proven to have broad and potent antifungal activity. In the present study, the pharmacokinetics of sertaconazole nail patches, developed for treatment of onychodystrophy and onychomycosis, were investigated in healthy volunteers. The objective of the study was to investigate the penetration of sertaconazole into the nail and plasma and the residual sertaconazole concentration in patches after 1 week of application onto the nails. METHODS: In a double-blind study, 16 healthy adults were treated with a 2.2cm nail patch containing sertaconazole 3.63mg and another patch containing no antifungal agent, which were placed on the left and right thumbnail of each subject, respectively (or vice versa), in a randomized order. The treatment period was 6 weeks and the patches were replaced weekly. Nail clippings, used nail patches, and blood samples were investigated to determine sertaconazole concentrations. RESULTS: Sertaconazole was detected in all sertaconazole-treated nail samples with mean concentrations of >100 µg/g, which exceeds the minimum inhibitory concentrations (MICs) for all relevant fungi in this context. Measurements of the residual dose in the patches suggested that 16–71% of the active ingredient had penetrated into the nail. No plasma sertaconazole concentrations could be detected. CONCLUSION: By virtue of their positive influence (occlusion) on water and lipid metabolism in dystrophic nails, nail patches should have beneficial therapeutic effects in onychodystrophic conditions. Addition of the antifungal agent sertaconazole adds broad-spectrum antimicrobial activity. In this study, the concentrations of sertaconazole in the nails were shown to be well above the MIC values for pathogenic fungi relevant to onychomycosis. No systemic absorption of the active ingredient was detectable, which should exclude unwanted systemic effects of the drug.
ACCESSION #
22027037

 

Related Articles

  • Fungal nail dystrophy. Chittari, Kim; Ilchyshyn, Andrew // Update;Jul2007, Vol. 75 Issue 1, p21 

    The article presents information on the diagnosis and the topical and systemic antifungal therapy of nail infection. In onychomycosis, the concentration of fungus is highest in the nail bed. Sublingual debris should be collected from the most proximal and lateral portion of the affected nail bed...

  • Topical Solution for Nail Fungus. Preboth, Monica // American Family Physician;10/1/2001, Vol. 64 Issue 7, p1280 

    Reports on the approval of ciclopirox topical solution, 8 percent, for the treatment of onychomycosis by the United States Food and Drug Administration. Description of the solution and its use; Side effects.

  • Treating Onychomycosis. Rodgers, Phillip; Bassler, Mary // American Family Physician;2/15/2001, Vol. 63 Issue 4, p663 

    Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents...

  • Terbinafine Is More Effective Than Itraconazole In Treating Toenail Onychomycosis: Results from a Meta-analysis of Randomized Controlled Trials. Krob, Alexander H.; Fleischer Jr., Alan B.; D'Agostino, Ralph; Feldman, Steven R. // Journal of Cutaneous Medicine & Surgery;Jul/Aug2003, Vol. 7 Issue 4, p306 

    Background: Toenail onychomycosis is a challenge for clinicians to treat, and this challenge is compounded by conflicting information in the medical literature concerning the efficacy of the two principal agents used in its treatment: terbinafine and itraconazole. Objective: The purpose of this...

  • Candida dubliniensis: A rare cause of nail infection. J. Kalsy; J. Kaur // Journal of Pakistan Association of Dermatologists;Oct-Dec2012, Vol. 22 Issue 4, p370 

    Candida dubliniensis is a newly described fungal opportunistic pathogen that is closely related phylogenetically to C. albicans. It is mostly isolated from patients with immunodeficiency and few cases develop quick resistance to routine treatment and delay in result outcome. Here we report a...

  • Diagnosing and Treating Onychomycosis. Zaias, Nardo; Glick, Brad; Rebell, Gerbert // Journal of Family Practice;May96, Vol. 42 Issue 5, p513 

    Onychomycosis is a persistent fungal infection of the toenails or fingernails that is usually not painful but is unsightly and can affect a patient's quality of life by interfering with footwear. It may affect up to 30% of the population by age 60. In more than 99% of cases, it is caused by...

  • Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China. Feng, Xiaobo; Ling, Bo; Yang, Xianwei; Liao, Wanqing; Pan, Weihua; Yao, Zhirong // Mycopathologia;Dec2015, Vol. 180 Issue 5/6, p365 

    Candida is a common cause of onychomycosis, especially for fingernail onychomycosis. In this study, two simple PCR-based assays combined with the internal transcribed spacers sequencing were performed to reveal the prevalence of Candida species including emerging species in onychomycosis, and...

  • Maxillary sinusitis caused by Lasiodiplodia theobromae. Kindo, A. J.; Pramod, C.; Anita, S.; Mohanty, S. // Indian Journal of Medical Microbiology;Apr2010, Vol. 28 Issue 2, p167 

    Lasiodiplodia (monotypic) comprises a very small proportion of the fungal biota. It is a common plant pathogen in tropical and subtropical regions. Clinical reports on its association with onychomycosis, corneal ulcer and phaeohyphomycosis are available. However, Lasiodiplodia theobromae causing...

  • Molecular Identification of Fusarium Species in Onychomycoses. Ninet, Béatrice; Jan, Isabelle; Bontems, Olympia; Léchenne, Barbara; Jousson, Olivier; Lew, Daniel; Schrenzel, Jacques; Panizzon, Renato G.; Monod, Michel // Dermatology (10188665);2005, Vol. 210 Issue 1, p21 

    Background:Fusarium species are isolated from about 3% of onychomycoses in the Swiss native population. On the basis of macroscopic characters and microscopic examination of the cultures, identification of Fusarium often remains difficult or uncertain because of variations from one isolate to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics